Investors
Don't miss any news, subscribe to our press releases.
Rights issue 2022
Summary of the rights issue
- Approximately 16 percent of the Rights Issue is covered by subscription commitments and approximately 59 percent by underwriting commitments, in total the Rights Issue is thus 75 percent covered.
- The subscription price per unit and thus per share amounts to SEK 0.75
- All existing shareholders will receive one (1) unit right for each one (1) share held on the record date October 28, 2022. One (1) unit right entitles the holder to subscribe for one (1) unit. One (1) unit consists of one (1) newly issued share and one (1) newly issued warrant of series TO5. The warrants are issued free of charge.
- The subscription period in the Rights Issue will run from November 1, 2022 to November 15, 2022. Trading in unit rights will run from November 1, 2022 to November 10, 2022. Unit rights that are not exercised during the subscription period will become invalid and lose their value.
- The subscription price for subscription of shares with warrants amounts to SEK 1.
- The exercise period for subscription of shares based on the warrants will run from May 15, 2023 to May 30, 2023.
Preliminary timetable for the Rights Issue
All dates refer to 2022
October 25, 2022 | Extraordinary General Meeting to approve the completion of the rights issue |
October 26, 2022 | Last day of trading in the Company's share with the right to receive unit rights |
October 27, 2022 | First day of trading in the Company's shares without the right to receive unit rights |
October 28, 2022 | Record date for receipt of unit rights |
31 October 2022 | Estimated date of publication of prospectus |
November 1, 2022 to November 15, 2022 inclusive | Subscription period for the Rights Issue |
November 1, 2022 to November 10, 2022 inclusive | Trading in unit rights |
November 18, 2022 | Estimated date for announcement of the outcome of the Rights Issue |
Read more about Sprint Bioscience and the offering: click here.
Documents for download
Invitation-to-subscribe-for-units-in-Sprint-Bioscience-AB-publ-
Communiqué-from-extra-annual-meeting-of-sprint-bioscience-ab-publ
Sprint-Bioscience-AB-publ-Consolidated-proposal-for-new-issue-with-preferred-rights-for-existing-shareholders-1
Sprint-bioscience-decides-on-transferred-issue-of-units-of-about-29-9-msec-conditional-on-subsequent-approval
Application form UF_units_Sprint_Bioscience
Sprint-Bioscience-AB-publ-Full-standard-conditions-for-warrants-TO5-1-1